An international team of researchers led by the University of Lincoln, UK, has produced two simplified versions of teixobactin, a powerful natural antibiotic which many in the scientific community believe could lead to creation of the first commercially viable new antibiotic drug in three decades. Teixobactin eliminates MRSA, Mycobacterium tuberculosis, Streptococcus pneumoniae, Bacillus anthracis and other dangerous pathogens without encountering...
